In vivo functional studies of tumor-specific retrogene NanogP8 in transgenic animals. - Wikidata - awgldk - TriplyDB

In vivo functional studies of tumor-specific retrogene NanogP8 in transgenic animals.

In vivo functional studies of tumor-specific retrogene NanogP8 in transgenic animals.

http://www.wikidata.org/entity/Q37344789

about

Insights into the Nanog gene: A propeller for stemness in primitive stem cells Concise Review: NANOG in Cancer Stem Cells and Tumor Development: An Update and Outstanding Questions Nanog1 in NTERA-2 and recombinant NanogP8 from somatic cancer cells adopt multiple protein conformations and migrate at multiple M.W species Tumor-suppressive functions of 15-Lipoxygenase-2 and RB1CC1 in prostate cancer Development of a Fluorescent Reporter System to Delineate Cancer Stem Cells in Triple-Negative Breast Cancer.Oncogenic NanogP8 expression regulates cell proliferation and migration through the Akt/mTOR signaling pathway in human gastric cancer - SGC-7901cell line Cisplatin induces stemness in ovarian cancer.An expressed retrogene of the master embryonic stem cell gene POU5F1 is associated with prostate cancer susceptibility.Stem cell transcription factor NANOG in cancers--is eternal youth a curse?Lineage-restricted function of the pluripotency factor NANOG in stratified epithelia.Transgenic overexpression of NanogP8 in the mouse prostate is insufficient to initiate tumorigenesis but weakly promotes tumor development in the Hi-Myc mouse model.NANOG reprograms prostate cancer cells to castration resistance via dynamically repressing and engaging the AR/FOXA1 signaling axis.Pluripotency factor Nanog is tumorigenic by deregulating DNA damage response in somatic cells.Report on the International Workshop 'Cancer stem cells: the mechanisms of radioresistance and biomarker discovery'.

P2860

Q28073695-1A535647-06C5-4AE0-927B-82FF55B2E6CC Q28088370-D07ADF21-6F8E-4295-BFE0-3E415E0CC31C Q28540510-3F96F1D3-5C3A-40F3-986F-E3C12C6E1778 Q33952990-BB4D2ED9-5985-4BEA-8795-3FE4337DA98A Q35827788-0B8BC78F-FFA3-4B5B-9908-48FBDD288EE6 Q37174814-EDF99642-47F9-4675-ADC0-D65099453D20 Q37327524-14C7BA6C-4695-46C8-AB28-AF4D5DD32CD3 Q38261890-14C3F4F8-3EC5-47FE-B699-708B92DC4607 Q38658623-122B2605-4961-4978-9829-6E90C6C088CD Q38979614-AF6598F7-5897-4F1B-8E06-7C494D2A3DCC Q41592884-2720112C-625A-4A01-A4ED-5648E328177E Q42368758-9039E042-A8B5-4890-809C-C7CC90B61367 Q45073527-52755649-0339-43D1-9DE6-007CFE9B68DB Q53089693-080E725A-1BD1-444B-B2ED-B848DDE64946

P2860

In vivo functional studies of tumor-specific retrogene NanogP8 in transgenic animals.

http://www.wikidata.org/entity/Q37344789

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 26 June 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

In vivo functional studies of tumor-specific retrogene NanogP8 in transgenic animals.

@en

In vivo functional studies of tumor-specific retrogene NanogP8 in transgenic animals.

@nl

type

label

In vivo functional studies of tumor-specific retrogene NanogP8 in transgenic animals.

@en

In vivo functional studies of tumor-specific retrogene NanogP8 in transgenic animals.

@nl

prefLabel

In vivo functional studies of tumor-specific retrogene NanogP8 in transgenic animals.

@en

In vivo functional studies of tumor-specific retrogene NanogP8 in transgenic animals.

@nl

P1433

Q37344789-62A4AB68-E2F9-4F49-9C53-3E2D3E295561

P1476

Q37344789-5D27CBDE-959B-4B23-B34C-1ACAAD92140A

P2093

Q37344789-25802ECD-CCBA-471B-B443-41E1E3DF75D4

Q37344789-55B53A9C-9D9A-473D-98D9-27F017D94D7E

Q37344789-5FB9EB95-809B-4DCF-9402-283CA8BDAE7A

Q37344789-703D3D2A-F4C7-4E39-8F59-63F2B4B0CDDF

Q37344789-78B07B78-6C31-4D36-B5E3-2F025FA075DE

Q37344789-A48C193C-AA10-4B9E-9418-B9FDC6FA879B

Q37344789-BE332A3C-0E62-4FBA-9281-BCBDCFFDA5E5

Q37344789-BF2E31BB-0D04-461A-8173-5026EC85D7D3

Q37344789-CA127626-6054-446D-AFF4-7878C32BA3EB

Q37344789-E83B42D2-E8AE-41CC-AD9D-7ED036D7852C

P2860

Q37344789-0308D6AA-020B-49C0-BB70-548324E4806D

Q37344789-06CABFA1-834E-40F7-9662-4BA4E752F8AC

Q37344789-0C0EA9BB-B47A-48B8-A1D2-C4F506848AF9

Q37344789-0C73214C-A9AE-4760-A0E5-5DB8063B3FE9

Q37344789-0E300E0A-2125-4E1E-AAE4-FBE6D9947DA9

Q37344789-0F0C0426-71D1-4ECA-8FDA-604FA6C94A86

Q37344789-0F6952E3-1CB9-4D77-B319-FF95A847B45F

Q37344789-14BF9164-BE40-478D-B877-E5CAAF0E1CED

Q37344789-164CB701-2DA9-4397-9285-E7CD0F7F03B1

Q37344789-176A5DE2-0604-4D4A-B2F3-359308D4F0D4

P304

Q37344789-63E6D937-546B-4873-9BBB-9D8C3F1BB757

P31

Q37344789-8677F867-C44F-4A33-BCE5-7E21DDB9CDCD

P356

Q37344789-0C46DABA-EE47-4828-828A-9476E2FD88BB

P433

Q37344789-EA25E412-04D1-4BBD-AF1E-974B10C28E73

P478

Q37344789-5C79ABD7-81ED-4E65-8B69-3C21EC2A91A0

P577

Q37344789-175BF806-C36C-4B66-BBAD-C0F74FCD1343

P5875

Q37344789-561EF27E-2C49-460B-8EFF-FE962135ABF9

P698

Q37344789-858A133F-6AD3-4343-8AB0-082418ECBABF

P932

Q37344789-9E495672-2BDD-4B45-A2F9-0850390C0338

P356

P1433

P1476

In vivo functional studies of tumor-specific retrogene NanogP8 in transgenic animals.

@en

P2093

Bigang Liu

http://www.w3.org/2001/XMLSchema#string

Collene R Jeter

http://www.w3.org/2001/XMLSchema#string

Dean G Tang

http://www.w3.org/2001/XMLSchema#string

Donna Kusewitt

http://www.w3.org/2001/XMLSchema#string

Joyce Rundhaug

http://www.w3.org/2001/XMLSchema#string

Mahipal V Suraneni

http://www.w3.org/2001/XMLSchema#string

Mark A Badeaux

http://www.w3.org/2001/XMLSchema#string

Shuai Gong

http://www.w3.org/2001/XMLSchema#string

Susan M Fischer

http://www.w3.org/2001/XMLSchema#string

Tao Yang

http://www.w3.org/2001/XMLSchema#string

P2860

Evidence that SOX2 overexpression is oncogenic in the lung

The PSA(-/lo) prostate cancer cell population harbors self-renewing long-term tumor-propagating cells that resist castration.

Identification and characterization of ovarian cancer-initiating cells from primary human tumors

Toll-like receptor 4 mediates synergism between alcohol and HCV in hepatic oncogenesis involving stem cell marker Nanog

Embryonic NANOG activity defines colorectal cancer stem cells and modulates through AP1- and TCF-dependent mechanisms

CD44posCD49fhiCD133/2hi defines xenograft-initiating cells in estrogen receptor-negative breast cancer

NANOG promotes cancer stem cell characteristics and prostate cancer resistance to androgen deprivation.

Identification of Pou5f1, Sox2, and Nanog downstream target genes with statistical confidence by applying a novel algorithm to time course microarray and genome-wide chromatin immunoprecipitation data.

Stem-cell-abundant proteins Nanog, Nucleostemin and Musashi1 are highly expressed in malignant cervical epithelial cells.

Nanog variability and pluripotency regulation of embryonic stem cells--insights from a mathematical model analysis.

P304

2395-2408

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4161/CC.25402

http://www.w3.org/2001/XMLSchema#string

P433

15

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P577

2013-06-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

248384286

http://www.w3.org/2001/XMLSchema#string

P698

23839044

http://www.w3.org/2001/XMLSchema#string

P932

3841319

http://www.w3.org/2001/XMLSchema#string